Description: eBreathie is an innovative and purpose-driven startup founded by a visionary team comprising a determined medical doctor, an innovative biomedical engineer, and a groundbreaking computer scientist. With a shared mission to revolutionize asthma management, they have developed a comprehensive digital health platform and a smart inhaler device. The eBreathie solution comprises three core components: the smart inhaler device, a user-friendly mobile app, and a specialized clinical platform. It tells patients and doctors two main things: when the patients did their medication and if they did it correctly. The mobile app empowers patients to monitor their asthma in real-time, access inhalation profiles, track symptoms, and receive medication adherence notifications. Simultaneously, the clinical platform provides healthcare providers with a comprehensive dashboard, facilitating telemedicine consults and enhancing therapeutic adherence and disease progression metrics. At the heart of eBreathie’s innovation lies its groundbreaking ability to predict asthma attacks before patients experience symptoms. This unique feature sets them apart from competitors, achieved through an AI-driven “Asthma Preview” algorithm integrated into their smart inhaler. By offering personalized insights and early intervention triggers, eBreathie aims to significantly improve patient outcomes.